JP2020509035A5 - - Google Patents

Download PDF

Info

Publication number
JP2020509035A5
JP2020509035A5 JP2019547371A JP2019547371A JP2020509035A5 JP 2020509035 A5 JP2020509035 A5 JP 2020509035A5 JP 2019547371 A JP2019547371 A JP 2019547371A JP 2019547371 A JP2019547371 A JP 2019547371A JP 2020509035 A5 JP2020509035 A5 JP 2020509035A5
Authority
JP
Japan
Prior art keywords
hepatocellular carcinoma
tumor
use according
microvascular
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019547371A
Other languages
English (en)
Japanese (ja)
Other versions
JP6948080B2 (ja
JP2020509035A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2018/077105 external-priority patent/WO2018157762A1/en
Publication of JP2020509035A publication Critical patent/JP2020509035A/ja
Publication of JP2020509035A5 publication Critical patent/JP2020509035A5/ja
Application granted granted Critical
Publication of JP6948080B2 publication Critical patent/JP6948080B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019547371A 2017-03-01 2018-02-24 手術後の肝細胞癌患者を治療するための薬剤の製造における硫酸化オリゴ糖の使用 Active JP6948080B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762465170P 2017-03-01 2017-03-01
US62/465,170 2017-03-01
US201762504552P 2017-05-11 2017-05-11
US62/504,552 2017-05-11
US201762551770P 2017-08-29 2017-08-29
US62/551,770 2017-08-29
PCT/CN2018/077105 WO2018157762A1 (en) 2017-03-01 2018-02-24 Use of sulfated oligosaccharides in the manufacture of a medicament for treating patients with hepatocellular carcinoma after surgical resection

Publications (3)

Publication Number Publication Date
JP2020509035A JP2020509035A (ja) 2020-03-26
JP2020509035A5 true JP2020509035A5 (https=) 2020-07-09
JP6948080B2 JP6948080B2 (ja) 2021-10-13

Family

ID=63357147

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019547371A Active JP6948080B2 (ja) 2017-03-01 2018-02-24 手術後の肝細胞癌患者を治療するための薬剤の製造における硫酸化オリゴ糖の使用

Country Status (6)

Country Link
US (1) US10842804B2 (https=)
JP (1) JP6948080B2 (https=)
KR (1) KR102265159B1 (https=)
CN (1) CN110381953A (https=)
TW (1) TWI693071B (https=)
WO (1) WO2018157762A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113160911A (zh) * 2021-02-26 2021-07-23 杭州臻合健康科技有限公司 一种用于术前肝功能耐受性分析的评估系统
CN117476246B (zh) * 2023-12-25 2024-04-19 福建大数据一级开发有限公司 基于多类型复发事件的患者生存分析方法、介质及装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103788141B (zh) * 2004-03-04 2016-08-17 普罗吉恩制药有限公司 硫酸化寡聚糖衍生物
KR20140050605A (ko) 2011-06-09 2014-04-29 메디젠 바이오테크놀로지 코프 간암의 재발, 악화 또는 전이 억제용 의약조성물

Similar Documents

Publication Publication Date Title
Lu et al. Recent advances in the prevention of hepatocellular carcinoma recurrence
Li et al. Polymer-and lipid-based nanoparticle therapeutics for the treatment of liver diseases
CN112675174B (zh) 多聚adp核糖聚合酶抑制剂治疗乙肝病毒相关疾病的新用途
Liu et al. Exosomes in HBV infection
Zhang et al. Current targeted therapeutics against COVID-19: based on first-line experience in China
Hu et al. Nobiletin, a novel inhibitor, inhibits HBsAg production and hepatitis B virus replication
JP2018184465A5 (https=)
JP2010520200A5 (https=)
Liu et al. Effects of antiviral therapy on HBV reactivation and survival in hepatocellular carcinoma patients undergoing hepatic artery infusion chemotherapy
JP2008514577A5 (https=)
JP2018522028A5 (https=)
JP2017514911A5 (https=)
CN111417402A (zh) 充分剂量条件下治疗乙肝病毒相关肝病的药物和方法
JP2020509035A5 (https=)
CN109364079B (zh) 塔拉帕尼在制备治疗或者预防肝炎病毒相关疾病药物中的用途
Jiang et al. Current status of drug therapy for chronic hepatitis B
EA200900558A1 (ru) Композиции аполактоферрина и способы их применения в лечении вирусного гепатита с
Wei et al. Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma
CN102600129A (zh) 穿心莲内酯c15位取代衍生物在制备抗丙型肝炎药物中的应用
RU2013120345A (ru) Новые способы лечения инфекции, вызванной вирусом гепатита с
JP2016503035A5 (https=)
CN102225069B (zh) 一种耐药性显著降低的药物组合物及其制备方法和其应用
Hu et al. Novel therapeutics in discovery and development for treatment of chronic HBV infection
Loustaud‐Ratti et al. Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
JP2020512408A5 (https=)